Ardsley Advisory Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,500
Closed -$291K 175
2020
Q2
$291K Buy
+4,500
New +$291K 0.06% 95